UC DIS.CERT. 09/24 CCC3/ DE000HD1X8F7 /
19/06/2024 17:45:34 | Var.- | Denaro18:56:35 | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
48.070EUR | - | - Quantità in denaro: 400 |
- Quantità in lettera: - |
COCA-COLA CO. D... | - - | 27/09/2024 | Call |
GlobeNewswire
08:10
IDEX Biometrics secures repeat order for IDEX Access from AuthenTrend for new markets
GlobeNewswire
07:53
freebeat and Boston Celtics: The Collaborative Power Behind Championship Victory
GlobeNewswire
07:33
Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order
GlobeNewswire
07:30
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of I...
GlobeNewswire
07:15
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
GlobeNewswire
07:00
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids a...
GlobeNewswire
07:00
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids a...
GlobeNewswire
07:00
Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting
GlobeNewswire
07:00
Technip Energies awarded a significant contract for IOCL’s grassroots naphtha cracking unit at Parad...
Newsfile Corp
06:47
Monarch Equity Capital Berhad Signs MoA with DR.IP Strategy Partner of Universiti Malaya Centre for ...
GlobeNewswire
06:36
OKX to Become First in CeFi to Launch AI-Powered Automated Trading Platform, Celebrates with 'Smart ...